Philips

Philips Ventures is the dedicated corporate venture capital arm of Royal Philips, a global leader in health technology. Established to strategically invest in and partner with innovative health technology companies, Philips Ventures plays a crucial role in advancing Philips' mission to improve people's health and well-being through meaningful innovation. The fund operates with a clear mandate to identify and support startups that align with Philips' core business segments and future growth areas, providing not only capital but also strategic guidance and access to Philips' extensive global network, market expertise, and technological resources. This collaborative approach aims to accelerate the development and adoption of breakthrough solutions in healthcare.

The investment focus of Philips Ventures is primarily on early to growth-stage companies within the HealthTech sector. Their key areas of interest include digital health, precision diagnosis, connected care solutions, and personal health technologies. This broad yet focused scope allows them to engage with a diverse range of innovations, from AI-powered diagnostic tools and remote patient monitoring platforms to consumer-facing health applications. As an active investor, Philips Ventures seeks to build long-term relationships with its portfolio companies, leveraging Philips' deep industry knowledge and R&D capabilities to help these ventures scale and achieve their full potential.

Philips Ventures typically participates in funding rounds ranging from Series A to Series C, with their individual check sizes varying based on the stage and specific needs of the investee company. While specific first check sizes can fluctuate, their investments often fall within the multi-million dollar range. For instance, Philips Ventures led a $20 million Series B funding round for Biobeat, a remote patient monitoring company, in 2021, demonstrating their capacity for significant lead investments. They have also participated in numerous Series A rounds, such as a $15 million Series A for Amplify Health in 2022, indicating their engagement with earlier-stage opportunities. With over 60 investments to date and a portfolio that includes companies like Cleerly and HeartFlow, Philips Ventures continues to be a prominent player in the health technology investment landscape, driving innovation and fostering strategic partnerships across the globe.